Latest News
Healthcare Cigna Group stock had its Relative Strength (RS) Rating upgraded to 86 Friday, up from 79 a day earlier.
Via Investor's Business Daily · April 4, 2025
Realty Income stock saw a welcome improvement to its Relative Strength (RS) Rating on Friday, rising from 75 to 82.
Via Investor's Business Daily · April 4, 2025
Via Benzinga · April 4, 2025
President Donald Trump‘s reciprocal tariffs on April 2 (weighted average tariff of 18.2%, inclusive of a 10% baseline tariff and varying levels by individual country) have the potential to impact end deman
Via Benzinga · April 4, 2025
Via Benzinga · April 4, 2025
Dell Technologies Inc. (NYSE: DELL) shares are trading lower Friday after Donald Trump declared a national emergency and introduced sweeping new tariffs targeting several major U.S. trade partners on Thursday.
Via Benzinga · April 4, 2025
Ethereum (CRYPTO: ETH) is down 18.4% over the past 30 days, a much steeper drop than Bitcoin's (CRYPTO:
Via Benzinga · April 4, 2025
Trump's 10% global tariff spares pharmaceuticals but impacts medical devices, with diabetes device makers facing the greatest strain. Large biopharma firms remain protected, while medtech companies navigate potential margin pressures and competitive shifts.
Via Benzinga · April 4, 2025
Wall Street's decline blamed on tech stocks, not Trump's tariffs. Treasury Secretary Scott Bessent says reassessment of AI valuations triggered selloff.
Via Benzinga · April 4, 2025
Celsius Holdings stock is making a comeback. Find out what's driving the energy drink maker's recent gains after a painful 2024.
Via The Motley Fool · April 4, 2025
Arvinas' ARV-102 reduced LRRK2 protein in a Phase 1 trial, showing promising safety and pharmacodynamic outcomes for Parkinson's and PSP treatment.
Via Benzinga · April 4, 2025
The digital advertising industry is expanding at 10% annually, providing a long-term growth opportunity for DoubleVerify.
Via Benzinga · April 4, 2025